PRESENTATIONS
Kateera F, Dorsey G, Achan J, Ruel T, Charlebois E, Havlir D, Rosenthal P, Kamya MR, Gasasira A. Efficacy, safety and tolerability of amodiaquine-artesunate verses artemether-lumefantrine for the treatment of uncomplicated malaria in HIV-infected children in Kampala, Uganda. Malaria Initiative Meeting (MIM), Nairobi, 11/2009.
Ruel T, Boal HE, Bangirana P, Akello C, Rosenthal PJ, Kamya MR, Charlebois ED, Havlir, DV, Boivin, MJ, Wong, JK, and Children with HIV and Malaria Project (CHAMP). Neurocognitive Impairment in HIV+ African Children Not Yet Eligible for Antiretroviral Therapy (ART). CROI, February 8-11, 2009, Montreal.
Achan J, Gasasira A, Ruel T, Kateera F, Kalyango J, Akello Caroline, Charlebois E, Dorsey G, Rosenthal P, Kamya M, Havlir D. A high risk of pneumonia in HIV infected African children persists up to six months after initiation of antiretroviral therapy (ART). CROI, February 8-11, 2009, Montreal.
Gasasira A, Diane Havlir, Jane Achan, Edwin Charlebois, Theodore Ruel, Philip Rosenthal, Taylor Sandison, Grant Dorsey and Moses Kamya. Prophylactic effect of trimethoprim-sulfamethoxazole against malaria in HIV-infected and exposed Ugandan children living in settings of high antifolate resistance. CROI, February 8-11, 2009, Montreal.
E. Charlebois D, Ruel T, Cao H, Gasasira A, Achan J, Kateera F, Akello C, Dorsey G, Wong J, Rosenthal P, Kamya M, Havlir D. Risk of short-term progression in Ugandan children not yet eligible for antiretroviral therapy (ART). XVII International AIDS Conference, August 03-08, 2008, Mexico City.
Gasasira A, Ruel T, Charlebois E, Achan A, Akello C, Kateera F, Rosenthal P, Dorsey G, Kamya M, Havlir D. Burden of significant bacterial infections in HIV-infected Ugandan children receiving trimethoprim-sulfamethoxazole prophylaxis. XVII International AIDS Conference, August 03-08, 2008, Mexico City.
Achan J, Ruel T, Kateera F, Kalyango J, Akello C, Gasasira A, Charlebois E, Dorsey G, Rosenthal P, Kekitiinwa A, Havlir D, Kamya M. Reconstitution Inflammatory Syndrome in the first 6 months of antiretroviral therapy in HIV-infected Ugandan children. XVII International AIDS Conference, August 03-08, 2008, Mexico City.
German, P. Parikh S, Lawrence J, Lindegårdh, N, Rosenthal P, Havlir D, Charlebois, E. Dorsey G, Aweeka, F. Drug Interaction between Antimalarial Drugs and Lopinavir/r. CROI 2008, Boston.
Ruel T, Ssewanyana I, Achan J, Gasasira A, Kamya M, Adeodata Kekitiinwa A, Wong J, Cao H, Havlir D, Charlebois E. Dynamics of T-cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children. Accepted by 15th CROI, Boston, February 3-6, 2008.
Bebel L, Pilcher C, Dorsey G, Havlir D, Kamya M, Busch M, Nugent C, Bentsen C, Charlebois E. Acute HIV-1 infection is highly prevalent in Ugandan Outpatients Suspected of Malaria. Submitted to CROI 2008, Boston.
Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G. High risk of neutropenia among HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Presented at the 56th Annual ASTMH meeting, November 04-08, 2007.
Achan, J, Ruel TD, Gasasira AF, Charlebois ED, Rosenthal PJ, Dorsey G, Kamya MR, Kekitiinwa A, Wong J, Havlir D, and the CHAMP team. Dramatic reductions in HIV RNA among HIV-infected children with acute measles in Uganda. Presented at the 56th Annual ASTMH meeting, November 04-08, 2007.
Yoel Lubell, Hopkins H, Whitty CJM, Staedke SG, Mills A. “Modelling the costs and benefits of HRP2 and pLDH RDTs for the detection of P. falciparum in Uganda,” 56th annual meeting of The American Society of Tropical Medicine & Hygiene, Philadelphia, Pennsylvania, Nov 2007.
Hopkins Hopkins, Kambale W, Bebell L, Dokomajilar C, Kamya MR, Staedke SG, Rosenthal PJ, Dorsey G. “Comparison of microscopy, HRP2- and pLDH-based rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda,” 56th annual meeting of The American Society of Tropical Medicine & Hygiene, Philadelphia, Pennsylvania, Nov 2007.
Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Theodore R, Kekitiinwa A, Charlebois ED, Rosenthal PJ, Havlir D, Dorsey G . “The effect of co-trimoxazole (CTX) prophylaxis and insecticide-treated bednets (ITN) on the risk of malaria among HIV infected Ugandan children. Presented at CROI,” Los Angeles, February 25-28, 2007.
Theodore RD, Achan J, Gasasira AF, Charlebois ED, Rosenthal PJ, Dorsey G, Kamya MR, Kekitiinwa A, Wong J, Havlir D, and the CHAMP Team. “Abstract #R123: Dramatic reductions in HIV RNA among HIV-infected children with acute measles in Uganda.” Presented at CROI, Los Angeles, February 25-28, 2007.
Bebell LM, Gasasira AF, Kiggundu M, Dokomajilar C, Kamya MR, Charlebois ED, Havlir D, Rosenthal PJ, Dorsey, G. “HIV-1 infection in patients referred for malaria blood smears at government health clinics in Uganda. Poster and Oral presentations at the Doris Duke Clinical Research Fellows National Meeting,” Boston, May 29-31, 2007.
Bebell, LM, Gasasira AF, Kiggundu M, Dokomajilar C, Kamya MR, Charlebois ED, Havlir D, Rosenthal PJ, Dorsey D. “HIV-1 infection in patients referred for malaria blood smears at government health clinics in Uganda. Abstract submitted to ASTMH for consideration for the 56th annual ASTMH meeting,” November 4-8, 2007.
Sarah Staedke, Mwebaza N, Kamya M, Dorsey G, Rosenthal PJ, Whitty CJM. “Evaluation of home-based management of fever in urban Ugandan children,” 55th annual meeting of The American Society of Tropical Medicine & Hygiene, Atlanta, Georgia, Nov 2006
Hasifa Bukirwa, Lubanga R, Nayiga S, Hopkins H, Yeka A, Talisuna A, Staedke S. “Pharmacovigilance of antimalarial treatment in Uganda: Establishing a surveillance system,” 55th annual meeting of The American Society of Tropical Medicine & Hygiene, Atlanta, Georgia, Nov 2006
Heidi Hopkins, Kambale W, Staedke S, Kamya M, Rosenthal PJ, Dorsey G. “Comparison of HRP2- and pLDH-based rapid diagnostic tests (RDTs) for malaria in Uganda,” 55th annual meeting of The American Society of Tropical Medicine & Hygiene, Atlanta, Georgia, Nov 2006
Kamya MR, Gasasira AF, Achan J, Mebrahtu T, Kekitiinwa A, Charlebois ED, Rosenthal PJ, Havlir D, Dorsey G. “The effect of co-trimoxazole prophylaxis and insecticide-treated bednets on the risk of malaria among HIV infected Ugandan children. ASTMH 55th Annual Meeting, November 12-16, 2006, Scientific Session 37, HIV in the Tropics.
Kamya MR, Brooks J, Ecuru J, Power M, Havlir D, Alston-Smith B, Mebrahtu T, Gasasira A, Hafner R. “Challenges of enrolling children in research conducted at international sites. Presented at Public Responsibility in Medicine and Research (PRIMR), ” Washington, D.C. November 15-18, 2006.
Ssewanyana I. “Distinct profile of immune response and effector responses in HIV positive Ugandan children. Poster presented at Immunology Research in Africa, December 7-8, 2006.
Sulggi A Lee, Yeka A, Nsobya SL, Dokomajilar C, Rosenthal PJ, Talisuna A, Dorsey G. “Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at seven sites in Uganda,” American Society of Tropical Medicine & Hygiene 54th Annual Meeting, Washington, DC, Dec 2005.
Hasifa Bukirwa, Yeka A, Bakyaita N, Talisuna A, Rosenthal PJ, Reingold A, Wabwire-Mangen F, Dorsey G, Kamya MR, Staedke SG. “Efficacy and safety of artemether-lumefantrine versus amodiaquine plus artesunate: Randomised controlled trial in Uganda,” Multilateral Initiative on Malaria Pan-African Conference, Yaoundé, Cameroon, Nov 2005.
Adoke Yeka. “Multi-site trial of combination antimalarial therapy: Evaluation of efficacy, safety and tolerability in Uganda,” 2nd Forum for European and Developing Countries Clinical Trials Partnership, Durban, South Africa, Oct 2005.
Adoke Yeka. “Monitoring the efficacy of ACTs in Uganda” and “A review of the implementation of the HBMF strategy in UPHOLD supported districts,” Malaria Consortium dissemination workshop on Implementing ACTs in Uganda, Kampala, Uganda, Sept 2005.
Moses R Kamya, Gasasira A, Yeka A, Bakyaita N, Nsobya SL, Francis D, Rosenthal PJ, Dorsey G, Havlir D. “The effect of HIV on malaria treatment outcome among adults and children with uncomplicated falciparum malaria in Uganda,” abstract TuPe1.4C13, 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, July 2005.
Anne Gasasira. “Effect of HIV infection on the response to antimalarial therapy in patients with uncomplicated malaria in Uganda,” NIAID International Centers for Tropical Disease Research Network 14th annual meeting, Bethesda, Maryland, May 2005.
Grant Dorsey. “Dihydrofolate reductase and dihydropteroate synthase genotypes and clinical response to sulfadoxine-pyrimethamine therapy alone and in combination,” American Society of Tropical Medicine & Hygiene 53rd Annual Meeting, Miami Beach, Florida, Nov 2004.
Sarah Staedke. “Combination antimalarial therapies: safety and assessment of adverse events in Uganda,” American Society of Tropical Medicine & Hygiene 53rd Annual Meeting, Miami Beach, Florida, Nov 2004.
Adoke Yeka. “Artemisinin verses non-artemisinin combination therapy for uncomplicated malaria: randomised clinical trials from four sites in Uganda,” American Society of Tropical Medicine & Hygiene 53rd Annual Meeting, Miami Beach, Florida, Nov 2004.
Ben Hunt, Dorsey G, Rosenthal PJ. “Does trimethoprim/sulfamethoxazole prophylaxis in HIV-infected patients select for Fansidar-resistant malaria?” 2nd Annual UCSF Global Health Symposium, April 2004.
Anne Gasasira. “Experiences of conducting antimalarial clinical trials in Kampala, Uganda,” African Malaria Network Trust (AMANET) 4th biennial conference, Arusha, Tanzania, Feb 2004.
Grant Dorsey. “Combining artesunate to sulfadoxine-pyrimethamine prevents increased rates of clinical treatment failure for sequential episodes of uncomplicated malaria in Uganda,” American Society of Tropical Medicine & Hygiene 52nd Annual Meeting, Philadelphia, Pennsylvania, Dec 2003.
Anne Gasasira. “The impact of age, temperature and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda,” American Society of Tropical Medicine & Hygiene 52nd Annual Meeting, Philadelphia, Pennsylvania, Dec 2003.
Sam Nsobya. “Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan Children,” American Society of Tropical Medicine & Hygiene 52nd Annual Meeting, Philadelphia, Pennsylvania, Dec 2003.
Sarah Staedke. “Proximity to mosquito breeding sites as a risk factor for clinical malaria in an urban cohort of Ugandan children,” American Society of Tropical Medicine & Hygiene 52nd Annual Meeting, Philadelphia, Pennsylvania, Dec 2003.
Grant Dorsey. “Longitudinal assessment of combination therapies for falciparum malaria in Kampala, Uganda: Improved efficacy and reduction of disease incidence,” Multilateral Initiative on Malaria Pan-African Conference, Arusha, Tanzania, Nov 2002.
Grant Dorsey. “The importance of longer term follow-up in antimalarial drug efficacy studies,” East African Network for Monitoring Antimalarial Therapy conference, Kigali, Rwanda, July 2002.
Anne Gasasira. “Antimalarial combination therapy for the treatment of uncomplicated falciparum malaria in Uganda,” Association of African Health Scientists 23rd annual meeting, Kampala, Uganda, April 2002.
Anne Gasasira. “Chloroquine or amodiaquine combined with Fansidar for the treatment of uncomplicated malaria in Kampala, Uganda,” American Society of Tropical Medicine & Hygiene 50th Annual Meeting, Atlanta, Georgia, Nov 2001.
Grant Dorsey. “Longitudinal assessment of combination therapies for falciparum malaria in Kampala, Uganda: Improved efficacy and reduction of disease incidence,” American Society of Tropical Medicine & Hygiene 50th Annual Meeting, Sept 2001.
Sarah Staedke. “The comparative efficacy of sulfadoxine-pyrimethamine, amodiaquine, and combination therapy for treatment of uncomplicated malaria in Kampala, Uganda,” American Society of Tropical Medicine & Hygiene 49th Annual Meeting, Nov 2000.
Anne Gasasira. “The current status of anti-microbial drug resistance,” Symposium on Common Infectious Disease in Uganda, [organized/sponsored by whom?], Sept 2000.
Moses R Kamya, Gasasira A, Ndeezi G, Babirye J, Dorsey G, Rosenthal PJ. “The comparative efficacy of chloroquine and pyrimethamine/sulfadoxine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda,” abstract 10346, 9th International Congress on Infectious Diseases, Buenos Aires, Argentina, April 2000.
Grant Dorsey. “Previously identified polymorphisms in pfcrt and pfmdr-1 are not predictive of in vivo chloroquine response in Kampala, Uganda,” American Society of Tropical Medicine & Hygiene 49th Annual Meeting, March 2000.
Grant Dorsey. “Epidemiological risk factors for chloroquine resistant malaria in children and adults in Kampala, Uganda,” Multilateral Initiative on Malaria Pan-African Conference, Durban, South Africa, March 1999.
Grant Dorsey. “Epidemiological risk factors for chloroquine resistant malaria in children and adults in Kampala, Uganda,” American Society of Tropical Medicine & Hygiene 48th Annual Meeting, Nov 1999.